Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers

PURPOSE: Patients with advanced/relapsed rare cancers have few treatment options. Analysis of circulating tumor DNA in plasma may identify actionable genomic biomarkers using a non-invasive approach. PATIENTS AND METHODS: Rare cancer patients underwent prospective plasma-based NGS testing. Tissue NG...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuma, Hitomi Sumiyoshi, Yonemori, Kan, Kojima, Yuki, Tanioka, Maki, Sudo, Kazuki, Noguchi, Emi, Hijioka, Susumu, Wakakuwa, Keiko, Kato, Ken, Hirakawa, Akihiro, Kuchiba, Aya, Kubo, Takashi, Ichikawa, Hitoshi, Yoshida, Akihiko, Yatabe, Yasushi, Nakamura, Kenichi, Mano, Hiroyuki, Yamamoto, Noboru, Fujiwara, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652216/
https://www.ncbi.nlm.nih.gov/pubmed/34900683
http://dx.doi.org/10.3389/fonc.2021.732525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652216/
https://www.ncbi.nlm.nih.gov/pubmed/34900683
http://dx.doi.org/10.3389/fonc.2021.732525

Ejemplares similares